Changes in the Incidence and Human Papillomavirus-Positive Portion of Oropharyngeal Squamous Cell Carcinoma in Hong Kong
- PMID: 38201653
- PMCID: PMC10778352
- DOI: 10.3390/cancers16010226
Changes in the Incidence and Human Papillomavirus-Positive Portion of Oropharyngeal Squamous Cell Carcinoma in Hong Kong
Abstract
The incidence of human papillomavirus (HPV)-associated oropharyngeal squamous cell carcinoma (OPSCC) is rising in the West, but little is known in Asia. This study elucidated changes in the incidence and HPV-positive portion of OPSCC in Hong Kong. Data from population-based cancer registry were used to analyze the incidence of OPSCC in association with other head and neck cancers. Archived tumor tissues were tested for HPV. From 1986 to 2020, there was a marked decrease in the incidence of nasopharyngeal and laryngeal cancers, but a persistent increase in OPSCC from 36 cases in 1986 to 116 cases in 2020. The average positive rate for high-risk HPV was 36.1% (112/310) among OPSCC diagnosed in 2010-2020. The HPV-positive rate in recent years was significantly higher than earlier cases (tonsil SCC: 64.7% (55/85) in 2016-2020 vs. 40.4% (19/47) in 2010-2015, p = 0.007). Patients with HPV-positive tonsil cancers were significantly younger than those negative (mean [SD]: 58.9 [9.9] vs. 64.3 [13.3] years, p = 0.006), but no significant difference was observed between genders. A persistent increase in the incidence of oropharyngeal cancer over the last few decades was observed in Hong Kong, which can be explained by the remarkable increase in HPV-positive tonsil cancers.
Keywords: Chinese; HPV; Hong Kong; OPSCC; head and neck cancers; oropharyngeal cancer; tonsil cancer.
Conflict of interest statement
P.K.S.C. received an honorarium from Merck Sharp and Dohme, GlaxoSmithKline, Moderna, and Pfizer for serving as speaker, advisor, or consultant. J.Y.K.C. and E.W.H.L. received an honorarium from Merck Sharp and Dohme for serving as a speaker, advisor, interpretation of data; in the writing of the manuscript; or in the decision to publish the results.
Figures
Similar articles
-
Sex Differences in Time Trends on Incidence Rates of Oropharyngeal and Oral Cavity Cancers in Hong Kong.Ann Otol Rhinol Laryngol. 2018 Dec;127(12):895-902. doi: 10.1177/0003489418802287. Epub 2018 Sep 29. Ann Otol Rhinol Laryngol. 2018. PMID: 30269509
-
Low prevalence of p16-positive HPV-related head-neck cancers in Thailand: tertiary referral center experience.BMC Cancer. 2019 Nov 6;19(1):1050. doi: 10.1186/s12885-019-6266-0. BMC Cancer. 2019. PMID: 31694600 Free PMC article.
-
Initial presentation of human papillomavirus-related head and neck cancer: A retrospective review.Laryngoscope. 2019 Apr;129(4):877-882. doi: 10.1002/lary.27296. Epub 2018 Sep 8. Laryngoscope. 2019. PMID: 30194702
-
Human papillomavirus (HPV) and oropharyngeal squamous cell carcinoma.Presse Med. 2014 Dec;43(12 Pt 2):e429-34. doi: 10.1016/j.lpm.2014.08.010. Epub 2014 Nov 11. Presse Med. 2014. PMID: 25455638 Review.
-
The molecular mechanisms of increased radiosensitivity of HPV-positive oropharyngeal squamous cell carcinoma (OPSCC): an extensive review.J Otolaryngol Head Neck Surg. 2018 Sep 21;47(1):59. doi: 10.1186/s40463-018-0302-y. J Otolaryngol Head Neck Surg. 2018. PMID: 30241572 Free PMC article. Review.
Cited by
-
Robotic Surgery for Head and Neck Tumors: What are the Current Applications?Curr Oncol Rep. 2024 Jul;26(7):840-854. doi: 10.1007/s11912-024-01546-1. Epub 2024 May 23. Curr Oncol Rep. 2024. PMID: 38777980 Free PMC article. Review.
References
-
- Gillison M.L., Koch W.M., Capone R.B., Spafford M., Westra W.H., Wu L., Zahurak M.L., Daniel R.W., Viglione M., Symer D.E., et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J. Natl. Cancer Inst. 2000;92:709–720. doi: 10.1093/jnci/92.9.709. - DOI - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials